arrow
S

Sophie Derchain

medical sciences
H指数:37
被引数:5,119

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Adjuvant capecitabine in women with triple-negative breast cancer with residual disease after carboplatin-containing neoadjuvant chemotherapy

含卡铂新辅助化疗后仍有残留病灶的三阴性乳腺癌患者辅助卡培他滨治疗

2026-03-300
OAAI
Association of NK6 homeobox 1 promoter methylation with HPV infection, histological subtype and patient outcomes in cervical lesions

NK6同源框1启动子甲基化与HPV感染、组织学亚型及患者结局在宫颈病变中的关联

2026-02-110
PRE
Is infracolic omentectomy necessary for presumed early-stage Borderline Ovarian Tumors (BOTs)? A retrospective cohort study and meta-analysis

是否需要切除疑似早期交界性卵巢肿瘤(BOTs)的结肠下大网膜?一项回顾性队列研究和荟萃分析

CLINICS
IF2.4
2025-11-010
PRE
Clarifying the Application of HIIT in Oncology Settings: a Response to “High-Intensity Interval Training for Cancer Patients: Taking Training Progression, Feasibility, and Patient Preferences into Account”

阐明高强度间歇训练在肿瘤学环境中的应用:对“癌症患者的高强度间歇训练:考虑训练进展、可行性和患者偏好”的回应

2025-06-260
PRE
Longitudinal, Long-Term Comparison of Single- versus Multipoint Upper Limb Circumference Periodical Measurements as a Tool to Predict Persistent Lymphedema in Women Treated Surgically for Breast Cancer: An Optimized Strategy to Early Diagnose Lymphedema and Avoid Permanent Sequelae in Breast Cancer Survivors

单点和多点上肢周长定期测量的纵向,长期比较作为预测乳腺癌手术治疗女性持续性淋巴水肿的工具: 乳腺癌幸存者早期诊断淋巴水肿和避免永久性后遗症的优化策略

2021-06-146
PRE
GSTP1 and ABCB1 Polymorphisms Predicting Toxicities and Clinical Management on Carboplatin and Paclitaxel-Based Chemotherapy in Ovarian Cancer

GSTP1和ABCB1多态性预测卵巢癌中基于卡铂和紫杉醇的化疗的毒性和临床管理

2020-12-1617
OAAI